| Drug | Class | Adult | Paediatric | Notes |
|---|---|---|---|---|
| Rifapentine + isoniazid (3HP)[1] | Weekly rifamycin + isoniazid | Rifapentine 900 mg + isoniazid 900 mg PO once weekly × 12 doses | Per weight, age ≥2 years per NTEP/WHO | Preferred regimen for HIV-negative and select HIV-positive individuals; better completion than 6H |
| Rifapentine + isoniazid (1HP)[1] | Daily 1-month rifapentine + isoniazid | Rifapentine 600 mg + isoniazid 300 mg PO daily × 28 days | Adults and ≥13 years | Shortest regimen, PLHIV indication; high completion rate |
| Rifampicin (4R)[1] | Daily rifampicin × 4 months | 10 mg/kg PO daily (max 600 mg) × 4 months | 10–20 mg/kg/day | Alternative; better completion than 6H; consider with INH-resistance contacts |
| Isoniazid (6H)[1] | Daily isoniazid × 6 months | 5 mg/kg (max 300 mg) PO daily × 6 months with pyridoxine 10 mg daily | 10 mg/kg/day max 300 mg | Traditional regimen; lower completion rates than shorter alternatives but still effective |
Identification and treatment of latent TB infection (LTBI) in high-risk groups; shorter rifamycin-based regimens preferred over 6-month isoniazid.